Editorial: Children, Asthma, and Proton Pump Inhibitors – Newswise (press release)

Editorial: Children, Asthma, and Proton Pump Inhibitors
Newswise (press release)
In an accompanying editorial, Fernando D. Martinez, MD, of the University of Arizona, Tucson, writes that the "overuse of PPIs in childhood asthma and in pediatrics in general is another example of a subtle but frequent phenomenon in clinical practice:

and more »

View full post on asthma – Google News

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders

Amira granted UK patents for AM103, AM803 FLAP inhibitors for respiratory disorders
Amira Pharmaceuticals, Inc. today announced that the U.K. Intellectual Property Office has granted patent number GB2431927, titled, “5-Lipoxygenase Activating Protein (FLAP) Inhibitors,” which includes coverage of Amira’s AM103 and AM803 FLAP inhibitors for the treatment of respiratory disorders.

Read more on News-Medical-Net